QIAGEN

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell QIAGEN and other ETFs, options, and stocks.

About QGEN

QIAGEN NV is a holding company, which engages in the provision of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. Its sample technologies isolate and process DNA, RNA, and proteins from blood, tissue, and other materials. 

CEO
Thierry L. Bernard
CEOThierry L. Bernard
Employees
5,654
Employees5,654
Headquarters
Venlo, Limburg
HeadquartersVenlo, Limburg
Founded
1996
Founded1996
Employees
5,654
Employees5,654

QGEN Key Statistics

Market cap
8.70B
Market cap8.70B
Price-Earnings ratio
21.87
Price-Earnings ratio21.87
Dividend yield
0.83%
Dividend yield0.83%
Average volume
2.29M
Average volume2.29M
High today
$42.58
High today$42.58
Low today
$41.97
Low today$41.97
Open price
$42.51
Open price$42.51
Volume
1.13M
Volume1.13M
52 Week high
$57.82
52 Week high$57.82
52 Week low
$32.53
52 Week low$32.53

Stock Snapshot

As of today, QIAGEN(QGEN) shares are valued at $42.22. The company's market cap stands at 8.7B, with a P/E ratio of 21.87 and a dividend yield of 0.83%.

During the trading session on 2026-08-07, QIAGEN(QGEN) shares reached a daily high of $42.58 and a low of $41.97. At a current price of $42.22, the stock is +0.6% higher than the low and still -0.9% under the high.

Trading activity shows a volume of 1.13M, compared to an average daily volume of 2.29M.

The stock's 52-week range extends from a low of $32.53 to a high of $57.82.

The stock's 52-week range extends from a low of $32.53 to a high of $57.82.

QGEN News

TipRanks 3h
Qiagen price target raised to $40 from $36 at Stifel

Stifel analyst Daniel Arias raised the firm’s price target on Qiagen (QGEN) to $40 from $36 and keeps a Hold rating on the shares. Unlock powerful investing to...

Investing.com 20h
QIAGEN Q2 2026 slides: flat growth masks strong pillar performance - Investing.com

...

QIAGEN Q2 2026 slides: flat growth masks strong pillar performance - Investing.com
Nasdaq 2d
QIAGEN Q2 Profit Rises

(RTTNews) - QIAGEN N.V. (QGEN) on Wednesday reported higher second-quarter earnings, while the molecular diagnostics company reaffirmed its full-year 2026 outlo...

QIAGEN Q2 Profit Rises

Analyst ratings

55%

of 22 ratings
Buy
45.5%
Hold
54.5%
Sell
0%

More QGEN News

TipRanks 3d
Barclays discloses 2.26% indirect stake in Qiagen

Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions Subscribe to TipRanks Smart Investor Newsletter, and...

Simply Wall St 6d
Qiagen Stock Could Be A Cash Flow Bargain Yet Fair On Earnings

Qiagen has delivered a roughly 20% decline over the past five years, yet the current share price around US$41.40 sits at a discount to its intrinsic value estim...

Qiagen Stock Could Be A Cash Flow Bargain Yet Fair On Earnings

People also own

Based on the portfolios of people who own QGEN. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.